246 related articles for article (PubMed ID: 28003512)
1. Characteristics of "American Snus" and Swedish Snus Products for Sale in Massachusetts, USA.
Seidenberg AB; Ayo-Yusuf OA; Rees VW
Nicotine Tob Res; 2018 Jan; 20(2):262-266. PubMed ID: 28003512
[TBL] [Abstract][Full Text] [Related]
2. Smokeless tobacco products sold in Massachusetts from 2003 to 2012: trends and variations in brand availability, nicotine contents and design features.
Cullen D; Keithly L; Kane K; Land T; Paskowsky M; Chen L; Hayes R; Li W
Tob Control; 2015 May; 24(3):256-62. PubMed ID: 24420311
[TBL] [Abstract][Full Text] [Related]
3. Is low-nicotine Marlboro snus really snus?
Foulds J; Furberg H
Harm Reduct J; 2008 Feb; 5():9. PubMed ID: 18304348
[TBL] [Abstract][Full Text] [Related]
4. Associations of Proposed Relative-Risk Warning Labels for Snus With Perceptions and Behavioral Intentions Among Tobacco Users and Nonusers.
Rodu B; Plurphanswat N; Hughes JR; Fagerström K
Nicotine Tob Res; 2016 May; 18(5):809-16. PubMed ID: 26253616
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of Dependence across Different Types of Nicotine Containing Products and Coffee.
Fagerstrom K
Int J Environ Res Public Health; 2018 Jul; 15(8):. PubMed ID: 30061507
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff.
Lunell E; Fagerström K; Hughes J; Pendrill R
Nicotine Tob Res; 2020 Oct; 22(10):1757-1763. PubMed ID: 32319528
[TBL] [Abstract][Full Text] [Related]
7. [Harm reduction strategy in tobacco control].
Gorini G
Epidemiol Prev; 2011; 35(3-4 Suppl 1):19-32. PubMed ID: 21926451
[TBL] [Abstract][Full Text] [Related]
8. Chemical analysis of snus products from the United States and northern Europe.
Lawler TS; Stanfill SB; Tran HT; Lee GE; Chen PX; Kimbrell JB; Lisko JG; Fernandez C; Caudill SP; deCastro BR; Watson CH
PLoS One; 2020; 15(1):e0227837. PubMed ID: 31940415
[TBL] [Abstract][Full Text] [Related]
9. Effect of smokeless tobacco (snus) on smoking and public health in Sweden.
Foulds J; Ramstrom L; Burke M; Fagerström K
Tob Control; 2003 Dec; 12(4):349-59. PubMed ID: 14660766
[TBL] [Abstract][Full Text] [Related]
10. Relative Risk Perceptions between Snus and Cigarettes in a Snus-Prevalent Society-An Observational Study over a 16 Year Period.
Lund KE; Vedoy TF
Int J Environ Res Public Health; 2019 Mar; 16(5):. PubMed ID: 30862006
[No Abstract] [Full Text] [Related]
11. Naturalistic assessment of demand for cigarettes, snus, and nicotine gum.
Stein JS; Wilson AG; Koffarnus MN; Judd MC; Bickel WK
Psychopharmacology (Berl); 2017 Jan; 234(2):245-254. PubMed ID: 27730273
[TBL] [Abstract][Full Text] [Related]
12. Alarming development of dual snus and cigarette usage among young Finnish males.
Danielsson M; Lammi A; Siitonen S; Ollgren J; Pylkkänen L; Vasankari T
BMC Public Health; 2019 Sep; 19(1):1249. PubMed ID: 31510968
[TBL] [Abstract][Full Text] [Related]
13. Symptoms of nicotine dependence in a cohort of Swedish youths: a comparison between smokers, smokeless tobacco users and dual tobacco users.
Post A; Gilljam H; Rosendahl I; Bremberg S; Galanti MR
Addiction; 2010 Apr; 105(4):740-6. PubMed ID: 20148785
[TBL] [Abstract][Full Text] [Related]
14. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
Stepanov I; Jensen J; Hatsukami D; Hecht SS
Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
[TBL] [Abstract][Full Text] [Related]
15. Dual use of cigarettes and Swedish snuff (snus) among young adults in Northern Finland.
Hamari AK; Toljamo TI; Kinnula VL; Nieminen PA
Eur J Public Health; 2013 Oct; 23(5):768-71. PubMed ID: 23002233
[TBL] [Abstract][Full Text] [Related]
16. Transnational tobacco company interests in smokeless tobacco in Europe: analysis of internal industry documents and contemporary industry materials.
Peeters S; Gilmore AB
PLoS Med; 2013; 10(9):e1001506. PubMed ID: 24058299
[TBL] [Abstract][Full Text] [Related]
17. Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum.
Lunell E; Curvall M
Nicotine Tob Res; 2011 Jul; 13(7):573-8. PubMed ID: 21454913
[TBL] [Abstract][Full Text] [Related]
18. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study.
Andersson G; Björnberg G; Curvall M
J Oral Pathol Med; 1994 Apr; 23(4):161-7. PubMed ID: 8046653
[TBL] [Abstract][Full Text] [Related]
19. Should the health community promote smokeless tobacco (snus) as a harm reduction measure?
Gartner CE; Hall WD; Chapman S; Freeman B
PLoS Med; 2007 Jul; 4(7):e185. PubMed ID: 17608560
[TBL] [Abstract][Full Text] [Related]
20. Harm reduction policies for tobacco users.
Gartner C; Hall W
Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
